According to the Centers for Disease Control and Prevention (CDC), depression alone causes 200 million lost work days each year, costing employers more than $44 billion.

Dr. Bonners, CEO of Magic Soap, saw the depth of mental health problems many workers faced during the pandemic, so he turned his attention to the drug ketamine, which is currently used to treat depression and anxiety.

At the beginning of June this year, the director of the Expio center, Vladyslav Matrenytskyi, took part in an international seminar on ketamine-assisted therapy in Barcelona (Spain), which was jointly organized by the "Sinaptica" clinic (Barcelona), the Dr. Scheib Institute (Mallorca) and the Ketamine Research Foundation (KRF). , USA).

During the comprehensive 5-day program, participants delved into the theory and practice of psychedelic ketamine therapy and gained the knowledge and skills necessary for confident independent use of these treatment methods.

During the seminar, Vladyslav Matrenytskyi spoke to the participants about the peculiarities of the use of ketamine therapy during the war in Ukraine.